Request News Alerts
Enter your Email
to receive News Alerts
for NBY

Due Diligence



NovaBay Pharmaceuticals, Inc. Logo
(NYSE MKT: NBY)
Healthcare
Enter your email to receive
the RedChip Money Report
weekly newsletter.
 
Money Report
Overview
NovaBay Pharmaceuticals is a clinical-stage biotechnology company focused on developing its proprietary and patented Aganocide® compounds. Aganocides are novel, broad-spectrum, fast-acting, synthetic anti-infectives designed to mimic the body's defense against infection. They are active against bacteria, fungi and viruses, and are being developed to treat and prevent a wide range of local, non-systemic infections with a low likelihood of developing bacterial resistance.
Stock Chart and Summary
Recent News
©2014 RedChip Companies, Inc. | "Discovering Tomorrow’s Blue Chips Today." ™ | Disclaimer | Disclosures | Policies